Hallmarks of Aging: Difference between revisions

Line 169: Line 169:
!Experimentally increasing it accelerates aging
!Experimentally increasing it accelerates aging
!Experimentally amending it slows the normal aging process and increases healthy lifespan.
!Experimentally amending it slows the normal aging process and increases healthy lifespan.
!Associated human diseases
|-
|-
| style="text-align:center; background-color:hsla(180, 100%, 85%);" |[[File:DNA Structure+Key+Labelled.pn NoBB.png|frameless|76x76px]]
| style="text-align:center; background-color:hsla(180, 100%, 85%);" |[[File:DNA Structure+Key+Labelled.pn NoBB.png|frameless|76x76px]]
Line 176: Line 177:
|Deficient DNA repair causes premature aging{{pmid|19812404}}
|Deficient DNA repair causes premature aging{{pmid|19812404}}
|Increased DNA repair facilitates greater longevity{{pmid|19812404}}
|Increased DNA repair facilitates greater longevity{{pmid|19812404}}
|
|-
|-
| style="text-align:center; background-color:hsla(180, 100%, 85%);" |[[File:Telomeres transparent.png|frameless|88x88px]]
| style="text-align:center; background-color:hsla(180, 100%, 85%);" |[[File:Telomeres transparent.png|frameless|88x88px]]
| style="background-color:hsla(180, 100%, 85%);" |'''Telomere attrition'''
| style="background-color:hsla(180, 100%, 85%);" |'''Telomere attrition'''
| style="background-color:hsla(180, 100%, 85%);" |
| style="background-color:hsla(180, 100%, 85%);" |Telomere attrition is a hallmark characterized by the progressive shortening of telomeres, due to the inability of DNA polymerases to fully replicate the ends of linear chromosomes. This shortening contributes to genomic instability, cellular aging, and limited cellular lifespan. Telomeres are protected by shelterin complexes; however, their deterioration or the absence of telomerase leads to cellular senescence and diseases.{{pmid|17024208}}{{pmid|18680434}}{{pmid|22426077}}{{pmid|22965356}}{{pmid|18252230}}{{pmid|18669893}}{{pmid|21205863}}{{pmid|20569239}}
|
|Telomere shortening is observed during normal aging in humans and mice{{pmid|17876321}}.
|
|Telomerase deficiency and severe uncapping of telomeres lead to premature aging and diseases{{pmid|22965356}}{{pmid|18680434}}{{pmid|18252230}}{{pmid|18669893}}{{pmid|21205863}}.
|Extension of telomeres through telomerase reactivation or other means can delay aging and extend lifespan without increasing cancer risk{{pmid|21113150}}{{pmid|22585399}}{{pmid|21426483}}{{pmid|23346961}}.
|
|
|-
|-
Line 187: Line 190:
| style="background-color:hsla(180, 100%, 85%);" |'''Epigenetic alterations'''
| style="background-color:hsla(180, 100%, 85%);" |'''Epigenetic alterations'''
| style="background-color:hsla(180, 100%, 85%);" |
| style="background-color:hsla(180, 100%, 85%);" |
|
|
|
|
|
Line 194: Line 198:
| style="background-color:hsla(210, 100%, 85%);" |'''Loss of proteostasis'''
| style="background-color:hsla(210, 100%, 85%);" |'''Loss of proteostasis'''
| style="background-color:hsla(210, 100%, 85%);" |
| style="background-color:hsla(210, 100%, 85%);" |
|
|
|
|
|
Line 200: Line 205:
| style="text-align:center; background-color:hsla(210, 100%, 85%);" |[[File:Macro-micro-autophagy.gif|frameless|101x101px]]
| style="text-align:center; background-color:hsla(210, 100%, 85%);" |[[File:Macro-micro-autophagy.gif|frameless|101x101px]]
| style="background-color:hsla(210, 100%, 85%);" |'''Disabled autophagy'''
| style="background-color:hsla(210, 100%, 85%);" |'''Disabled autophagy'''
| style="background-color:hsla(210, 100%, 85%);" |  
| style="background-color:hsla(210, 100%, 85%);" |
|
|
|
|
|
Line 207: Line 213:
| style="text-align:center; background-color:hsla(0, 100%, 85%);" |[[File:Aiga restaurant knife-fork crossed.png|frameless|75x75px]]
| style="text-align:center; background-color:hsla(0, 100%, 85%);" |[[File:Aiga restaurant knife-fork crossed.png|frameless|75x75px]]
| style="background-color:hsla(0, 100%, 85%);" |'''Deregulated nutrient sensing'''
| style="background-color:hsla(0, 100%, 85%);" |'''Deregulated nutrient sensing'''
| style="background-color:hsla(0, 100%, 85%);" |  
| style="background-color:hsla(0, 100%, 85%);" |
|
|
|
|
|
Line 215: Line 222:
| style="background-color:hsla(0, 100%, 85%);" |'''Mitochondrial dysfunction'''
| style="background-color:hsla(0, 100%, 85%);" |'''Mitochondrial dysfunction'''
| style="background-color:hsla(0, 100%, 85%);" |  
| style="background-color:hsla(0, 100%, 85%);" |  
|
|
|
|
|
Line 222: Line 230:
| style="background-color:hsla(30, 100%, 85%);" |[[Senescent Cells|'''Cellular senescence''']]
| style="background-color:hsla(30, 100%, 85%);" |[[Senescent Cells|'''Cellular senescence''']]
| style="background-color:hsla(30, 100%, 85%);" |
| style="background-color:hsla(30, 100%, 85%);" |
|
|
|
|
|
Line 229: Line 238:
| style="background-color:hsla(30, 100%, 85%);" |'''Stem cell exhaustion'''
| style="background-color:hsla(30, 100%, 85%);" |'''Stem cell exhaustion'''
| style="background-color:hsla(30, 100%, 85%);" |
| style="background-color:hsla(30, 100%, 85%);" |
|
|
|
|
|
Line 237: Line 247:
'''(Microbiome disturbance)'''
'''(Microbiome disturbance)'''
| style="background-color:hsla(30, 100%, 85%);" |
| style="background-color:hsla(30, 100%, 85%);" |
|
|
|
|
|
Line 245: Line 256:
'''(Inflammaging)'''
'''(Inflammaging)'''
| style="background-color:hsla(30, 100%, 85%);" |
| style="background-color:hsla(30, 100%, 85%);" |
|
|
|
|
|
Line 252: Line 264:
| style="background-color:hsla(30, 100%, 85%);" |'''Altered intercellular communication'''
| style="background-color:hsla(30, 100%, 85%);" |'''Altered intercellular communication'''
| style="background-color:hsla(30, 100%, 85%);" |
| style="background-color:hsla(30, 100%, 85%);" |
|
|
|
|
|
|
|
|}
|}


==History==
==History==